Grignard Pure is a Game-Changing Solution for a World-changing Problem

The First-Ever Airborne Antiviral Solution Approved by the EPA to Fight COVID-19


First-ever airborne antiviral product approved by the EPA to help fight the spread of COVID-19


Among the only regulated antimicrobial air treatment solutions available


Kills 98% of the SARS-CoV-2 virus in the air where transmission is most likely


Provides continuous coverage and protection when in use


Monitored visually and via sensors regardless of air exchanges

Get the Facts on Health and Safety

Grignard Pure™ is a rigorously tested, EPA-approved airborne antivial solution that kills 98% of SARS-CoV-2 virus particles in the air, when people are present, and where the CDC has told us that transmission is most likely. It is the first-ever airborne antiviral product approved by the EPA to help fight the spread of COVID-19, providing a critical added layer of protection, killing virus particles as they enter the air from talking, coughing, sneezing and reducing what is the primary cause of infection. Please download our full Grignard Pure Health and Safety Fact Sheet to learn all the health and safety facts.

If you have questions about Grignard Pure or are interested in learning more about how to partner with us as a distributor, installer or engineer, please call us:

1 (855) 642-PURE (7873)

Grignard Pure is an antimicrobial air treatment technology that kills 98% of the SARS-CoV-2 virus in the air, in occupied and unoccupied spaces — where transmission is most likely. The product is continuously effective when in use.

Between January 15, 2021 and July 2, 2021, Grignard Pure, LLC received approval from the EPA (Environmental Protection Agency) under its Section 18 Public Health Emergency Exemption program that allows for the use of the technology solution in Georgia, Tennessee, Maryland, Texas, Pennsylvania, Nevada and Virginia in specific indoor locations as determined by the EPA as part of its evaluation and research.

In January, 2022 the EPA re-authorized the Emergency Exemption use of Grignard Pure in all seven states. The authorization is current through January 15, 2023, at which point the states will exercise the option of seeking a renewal for an additional year.

Grignard Pure reduces the levels of airborne virus particles, making it an added, critical component in a safety protocol that includes personal hygiene, wearing a protective mask, practicing social distancing and ventilation..

Grignard Pure is grounded in a legacy of chemistry innovation and a vision built on science credibility. Grignard ancestor Victor Grignard won the Nobel Prize in Chemistry for “the Grignard reagent.” Grignard Pure’s Advisory Team includes public health, environmental science and engineering, microbiology, and pharmacology doctors from institutions including Harvard, Oxford, Rutgers, Johns Hopkins and NYU.